Trial NCT03818672

View at ClinicalTrials.gov 
Org. Study IDs: RFPK4045

Last trial update was posted on 2023-11-30

MeSH Interventions

Rifaximin

MeSH Conditions

Liver Diseases

Other Conditions

Severe Hepatic Impairment

Stopping Reasons

Study determined to be infeasible.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID